These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37401314)

  • 21. The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus.
    Rosenblatt S; Miskin B; Glazer NB; Prince MJ; Robertson KE;
    Coron Artery Dis; 2001 Aug; 12(5):413-23. PubMed ID: 11491207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid Biomarkers as Predictors of Diastolic Dysfunction in Diabetes with Poor Glycemic Control.
    Khedr D; Hafez M; Lumpuy-Castillo J; Emam S; Abdel-Massih A; Elmougy F; Elkaffas R; Mahillo-Fernández I; Lorenzo O; Musa N
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Association of lipid parameters with insulin resistance in different glycemic among the elderly population].
    Pang SJ; Man QQ; Song S; Song PK; Liu Z; Li YQ; He L; Zhao WH; Zhang J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jun; 52(6):629-635. PubMed ID: 29886685
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of Glycemic Control, Lifestyle and Clinical Characteristics in Patients with Type 2 Diabetes Treated at King Abdullah University Hospital in Jordan.
    Al-Eitan LN; Nassar AM; Saadeh NA; Almomani BA
    Can J Diabetes; 2016 Dec; 40(6):496-502. PubMed ID: 27212046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex-specific differences in glycemic control and cardiovascular risk factors in older patients with insulin-treated type 2 diabetes mellitus.
    Göbl CS; Brannath W; Bozkurt L; Handisurya A; Anderwald C; Luger A; Krebs M; Kautzky-Willer A; Bischof MG
    Gend Med; 2010 Dec; 7(6):593-9. PubMed ID: 21195359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Effect of Vitamin D Supplementation on Glycemic Control and Lipid Profile in Patients with Type 2 Diabetes Mellitus.
    Mohamad MI; El-Sherbeny EE; Bekhet MM
    J Am Coll Nutr; 2016 Jul; 35(5):399-404. PubMed ID: 26391639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and correlation of glycemic control achievement in patients with type 2 diabetes in Iraq: A retrospective analysis of a tertiary care database over a 9-year period.
    Mansour AA; Alibrahim NTY; Alidrisi HA; Alhamza AH; Almomin AM; Zaboon IA; Kadhim MB; Hussein RN; Nwayyir HA; Mohammed AG; Al-Waeli DKJ; Hussein IH;
    Diabetes Metab Syndr; 2020; 14(3):265-272. PubMed ID: 32272433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of outpatient diabetes management on serum lipids in urban African-Americans with type 2 diabetes.
    Erdman DM; Cook CB; Greenlund KJ; Giles WH; El-Kebbi I; Ryan GJ; Gallina DL; Ziemer DC; Dunbar VG; Phillips LS
    Diabetes Care; 2002 Jan; 25(1):9-15. PubMed ID: 11772894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of associated conditions on glycemic control of NIDDM patients.
    Ferrannini E; Stern MP; Galvan AQ; Mitchell BD; Haffner SM
    Diabetes Care; 1992 Apr; 15(4):508-14. PubMed ID: 1499466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors associated with glycemic control among South African adult residents of Mkhondo municipality living with diabetes mellitus.
    Masilela C; Pearce B; Ongole JJ; Adeniyi OV; Benjeddou M
    Medicine (Baltimore); 2020 Nov; 99(48):e23467. PubMed ID: 33235135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.
    Derosa G; Cicero AF; Gaddi A; Ragonesi PD; Fogari E; Bertone G; Ciccarelli L; Piccinni MN
    Clin Ther; 2004 May; 26(5):744-54. PubMed ID: 15220018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein metabolism in patients with type 1 diabetes under intensive insulin treatment.
    Feitosa AC; Feitosa-Filho GS; Freitas FR; Wajchenberg BL; Maranhão RC
    Lipids Health Dis; 2013 Feb; 12():15. PubMed ID: 23398881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of concentrated beetroot juice consumption on glycemic control, blood pressure, and lipid profile in type 2 diabetes patients: randomized clinical trial study.
    Karimzadeh L; Sohrab G; Hedayati M; Ebrahimof S; Emami G; Razavion T
    Ir J Med Sci; 2023 Jun; 192(3):1143-1153. PubMed ID: 35869311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ciprofibrate effects on carbohydrate and lipid metabolism in type 2 diabetes mellitus subjects.
    Hernández-Mijares A; Lluch I; Vizcarra E; Martínez-Triguero ML; Ascaso JF; Carmena R
    Nutr Metab Cardiovasc Dis; 2000 Feb; 10(1):1-6. PubMed ID: 10812581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of high vs low glycemic index of dietary carbohydrate on cardiovascular disease risk factors and insulin sensitivity: the OmniCarb randomized clinical trial.
    Sacks FM; Carey VJ; Anderson CA; Miller ER; Copeland T; Charleston J; Harshfield BJ; Laranjo N; McCarron P; Swain J; White K; Yee K; Appel LJ
    JAMA; 2014 Dec; 312(23):2531-41. PubMed ID: 25514303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of pioglitazone on glycemic and lipid parameters and adverse events in elderly patients with type 2 diabetes mellitus: a post hoc analysis of four randomized trials.
    Rajagopalan R; Xu Y; Abbadessa M;
    Am J Geriatr Pharmacother; 2006 Jun; 4(2):123-33. PubMed ID: 16860259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of dyslipidemia and the relationship between HbA1C and lipid profile in Moroccan patients with T2DM: a cross-sectional study.
    Alami HE; Haddou I; Benaadi G; Lkhider M; Wakrim L; Allali M; Abidi O; Ghazal H; Idrissi NA; Nabih N; Naamane A; Maaroufi A; Khlil N; Hamdi S
    Pan Afr Med J; 2022; 43():86. PubMed ID: 36605985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managing type 2 diabetes: going beyond glycemic control.
    Stolar MW; Hoogwerf BJ; Gorshow SM; Boyle PJ; Wales DO
    J Manag Care Pharm; 2008 Jun; 14(5 Suppl B):s2-19. PubMed ID: 18597582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved glycemic control increases fasting plasma acylation-stimulating protein and decreases leptin concentrations in type II diabetic subjects.
    Ozata M; Gungor D; Turan M; Ozisik G; Bingol N; Ozgurtas T; Ozdemir IC
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3659-64. PubMed ID: 11502793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin. A multicenter, randomized, double-blind, placebo-controlled trial.
    Yale JF; Valiquett TR; Ghazzi MN; Owens-Grillo JK; Whitcomb RW; Foyt HL
    Ann Intern Med; 2001 May; 134(9 Pt 1):737-45. PubMed ID: 11329231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.